These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38540776)

  • 1. Exploring SVA Insertion Polymorphisms in Shaping Differential Gene Expressions in the Central Nervous System.
    Hughes LS; Fröhlich A; Pfaff AL; Bubb VJ; Quinn JP; Kõks S
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Genome-Wide Screen for the Exonisation of Reference SINE-VNTR-Alus and Their Expression in CNS Tissues of Individuals with Amyotrophic Lateral Sclerosis.
    Pfaff AL; Bubb VJ; Quinn JP; Koks S
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the Function of a SINE-VNTR-
    Fröhlich A; Pfaff AL; Bubb VJ; Koks S; Quinn JP
    Front Mol Neurosci; 2022; 15():815695. PubMed ID: 35370538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SVA Regulation of Transposable Element Clustered Transcription within the Major Histocompatibility Complex Genomic Class II Region of the Parkinson's Progression Markers Initiative.
    Kulski JK; Pfaff AL; Koks S
    Genes (Basel); 2024 Sep; 15(9):. PubMed ID: 39336776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression Quantitative Trait Loci (eQTLs) Associated with Retrotransposons Demonstrate their Modulatory Effect on the Transcriptome.
    Koks S; Pfaff AL; Bubb VJ; Quinn JP
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of retrotransposon insertion polymorphisms in whole genome sequencing data from individuals with amyotrophic lateral sclerosis.
    Savage AL; Iacoangeli A; Schumann GG; Rubio-Roldan A; Garcia-Perez JL; Al Khleifat A; Koks S; Bubb VJ; Al-Chalabi A; Quinn JP
    Gene; 2022 Nov; 843():146799. PubMed ID: 35963498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of SINE-VNTR-Alu (SVA) Retrotransposons in Shaping the Human Genome.
    Gianfrancesco O; Geary B; Savage AL; Billingsley KJ; Bubb VJ; Quinn JP
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the role of a SINE-VNTR-Alu retrotransposon polymorphism as a biomarker of Parkinson's disease progression.
    Fröhlich A; Pfaff AL; Middlehurst B; Hughes LS; Bubb VJ; Quinn JP; Koks S
    Sci Rep; 2024 May; 14(1):10932. PubMed ID: 38740892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The landscape of human SVA retrotransposons.
    Chu C; Lin EW; Tran A; Jin H; Ho NI; Veit A; Cortes-Ciriano I; Burns KH; Ting DT; Park PJ
    Nucleic Acids Res; 2023 Nov; 51(21):11453-11465. PubMed ID: 37823611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR deletion of a SINE-VNTR-
    Fröhlich A; Hughes LS; Middlehurst B; Pfaff AL; Bubb VJ; Koks S; Quinn JP
    Front Neurol; 2023; 14():1273036. PubMed ID: 37840928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of polymorphic transposable elements on transcription in lymphoblastoid cell lines from public data.
    Spirito G; Mangoni D; Sanges R; Gustincich S
    BMC Bioinformatics; 2019 Nov; 20(Suppl 9):495. PubMed ID: 31757210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.
    Savage AL; Wilm TP; Khursheed K; Shatunov A; Morrison KE; Shaw PJ; Shaw CE; Smith B; Breen G; Al-Chalabi A; Moss D; Bubb VJ; Quinn JP
    PLoS One; 2014; 9(6):e90833. PubMed ID: 24608899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A SINE-VNTR-
    Hall A; Moore AK; Hernandez DG; Billingsley KJ; Bubb VJ; Quinn JP; Nabec North American Brain Expression Consortium
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-reference genome transposable elements (TEs) have a significant impact on the progression of the Parkinson's disease.
    Kõks S; Pfaff AL; Singleton LM; Bubb VJ; Quinn JP
    Exp Biol Med (Maywood); 2022 Sep; 247(18):1680-1690. PubMed ID: 36000172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference LINE-1 insertion polymorphisms correlate with Parkinson's disease progression and differential transcript expression in the PPMI cohort.
    Fröhlich A; Pfaff AL; Bubb VJ; Quinn JP; Koks S
    Sci Rep; 2023 Aug; 13(1):13857. PubMed ID: 37620405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complex.
    Kulski JK; Pfaff AL; Marney LD; Fröhlich A; Bubb VJ; Quinn JP; Koks S
    Exp Biol Med (Maywood); 2023 Dec; 248(23):2304-2318. PubMed ID: 38031415
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Haring NL; van Bree EJ; Jordaan WS; Roels JRE; Sotomayor GC; Hey TM; White FTG; Galland MD; Smidt MP; Jacobs FMJ
    Genome Res; 2021 Apr; 31(4):551-563. PubMed ID: 33722937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference SVA insertion polymorphisms are associated with Parkinson's Disease progression and differential gene expression.
    Pfaff AL; Bubb VJ; Quinn JP; Koks S
    NPJ Parkinsons Dis; 2021 May; 7(1):44. PubMed ID: 34035310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR Deletion of a SVA Retrotransposon Demonstrates Function as a
    Price E; Gianfrancesco O; Harrison PT; Frank B; Bubb VJ; Quinn JP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SVA retrotransposons as potential modulators of neuropeptide gene expression.
    Gianfrancesco O; Bubb VJ; Quinn JP
    Neuropeptides; 2017 Aug; 64():3-7. PubMed ID: 27743609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.